Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides-Reference-Cited by-同舟云学术

Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides

Author:

Breeman Wouter A.P.,Fröberg A.C.,de Blois E.,van Gameren A.,Melis M.,de Jong M.,Maina T.,Nock B.A.,Erion J.L.,Mäcke H.R.,Krenning E.P.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference35 articles.

2. Evaluation of a DOTA-minigastrin derivative for therapy and diagnosis for CCK-2 receptor positive tumours;Behe;Eur J Nucl Med Mol Imaging,2005

5. Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors;Behr;J Nucl Med,1999

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Theranostic Radiopeptides in Nuclear Oncology: Design, Preclinical Screening, and Clinical Translation;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024